How Medaka Box Has Survived This Far
How Medaka Box Has Survived This Far
There seems to be some misconceptions, ridiculous claims, and outright retarded hatred in terms of how this series has managed to live. I’m making this post to clear a few things up and break it down step by step and destroy some of the inane crap I’ve read in various forums. Hopefully by the end of this post, more people will see reason. Although I also expect those cemented in their irrational hatred to still keep on hating just to hate. In reality, it is the combination of sales and even the devil’s luck that has kept Medaka Box living on. The fact that it debuted in a year where long-running series in Eyeshield 21, Neuro, To Love Ru, and D.Gray-man were moving and/or ending also helped a lot. Part of that devil’s luck I mentioned before.
While Medaka was on week 6 of its preliminary 8 weeks of rankings, Eyeshield 21 ended. Medaka’s first official ranking came along when Hoop Men ended which was the resident bottom feeder this round.
To Love Ru had an abrupt ending due to Yabuki’s personal reasons and DGM moved over to the Jump SQ monthly magazine. This managed to save both Medaka Box and Akaboshi from getting the axe.
Kagijin, which had been ranking dead last ever since its 2nd chapter, was canceled. Its end was obvious.
Akaboshi, which didn’t sell anywhere near as much as Medaka Box, was the next to go. It more ranked lower than Medaka more often than above it. Although the battle between the two seemed very heated ranking-wise, Medaka came out on top.
Wajimania, a short gag series, was also canceled in this round. Many people were expecting this one to go anyway.
Ane-doki started tanking in the standings after starting off as a solid middle-ranked series and even getting a couple of color pages.
You can see the first signs of it weakening at Issue 50 2009 and it just sinks like a rock from Issue 1 onwards. The weeks leading up to its final chapters were all in last place while Medaka still managed to be above it at various positions of the bottom 5. It is now more likely that this cancellation came about because of Hunter x Hunter’s return. Especially considering the last chapter came in the issue after Hunter x Hunter returned. Though Ane-doki had great volume 1 sales(93K in 2 weeks,109K in a month) for a new series and even outsold Medaka’s 2nd volume(82K in 2 weeks), the Jump editors would have to have already made the decision to cancel it without getting full feedback on how the volume did since they make those decisions at least a month in advance. Ane-doki’s last chapter was announced on Jan 5th and its first volume went on sale Dec 4th. So clearly the decision to cancel it was already set in stone within the editorial department as volume 1 was going on sale. WSJ was not going to go and call back several weeks worth of chapters for the magazine in motion just to keep Ane-Doki.
Now a lot of people bitch and moan about this face off the two series had. But what most likely saved Medaka this time was the fact that it had been serialized before Ane-doki and thus already had one volume to have its sales measured and worth keeping. As I mentioned earlier, Medaka volume 1 was under printed originally but had to be reprinted because it kept selling, almost breaking 100K by the time December came around. Which was the month both Medaka vol. 2 and Ane-doki vol. 1 came about. Space needed to be made for Hunter x Hunter and if Ane-Doki actually had a volume out before that time, it would have been more likely to continue on. Either way, those are the reasons for why Medaka came out on top over this one though there are still bitter Ane-Doki fans that like to blame Medaka Box for it being canceled. (When really they should be pointing the finger at HxH’s re-serialization timing)
Side Note: Medaka Box’s 3rd volume has outsold Ane-Doki’s 2nd volume in its first week Medaka got 72K while Ane-Doki got 56K. In the 2nd week, Medaka rose to 96K while Ane-Doki fell off the chart and I can’t ascertain how well it did in its 2nd week. After the battle that has been fought over these two, it feels great to have Medaka not only come out on top this round but also increase its sales. Meanwhile Ane-doki showed minimal improvement then proceeded to plummet. Needless to say, it isn’t matching volume 1’s output and for good reason imo. (I’ll go into detail here when I make my Ane-Doki post)
Neko Wappa which had been in last place since its 2nd chapter ended.
Kanata Seven Change was a bit of a weird choice but not surprising. It never got below 4th from last but it was still frequenting the bottom 5 for most of its ranked chapters. At this point, Medaka has had 2 high selling volumes for a new series with the 3rd about to be released within the next month of when this decision was made. WSJ definitely wasn’t planning on getting rid of it when it had so many other options this time around. Some of which includes Rilienthal and Hokenshitsu no Shinigami. But even these two series managed to continue on while Kanata Seven Change takes the bullet for them and Medaka Box.
Nishio Ishin’s Name Has Not Saved/Protected Medaka Box
A lot of haters and bitter fans of other canceled series(Akaboshi and Ane-Doki) like to say that this series gets special treatment(Hint: Kuroko no Basket is WSJ’s reigning king). The manga can not have survived off of Nishio Ishin’s name. When volume 1 came out they under printed the series and it only had 15K copies. If they were trying to use his name, they would have printed out far more and they would have been pimping it with color pages like with Kuroko and Beelzebub. The “author name” claim is incorrect because Medaka Box was serialized before Bakemonogatari even aired for one. It was serialized in May 2009 while Bakemonogatari did not air until summer that year. Most of Nishio’s mainstream explosion came from this anime. Most of the light novel readers actually rate his Zaregoto novel over the Bakemonogatari one so it wasn’t the novel itself that caused the explosion but the anime.
Bakemonogatari’s DVD sales don’t factor in either considering that Medaka Box’s sales for a new series are formidable in its own right. Going one step further, Bakemonogatari’s massive sales didn’t even materialize until the week of Sept 28th-Oct 4th 2009 when the first volume went on sale. Medaka Box’s first volume also went on sale that week. I already mentioned how the latter had been under printed at various points in this entry. Seriously, what publishing company under prints a series that has a supposed big name behind it? This series was clearly underestimated. Which isn’t something that should happen with big named authors.
By the time the next cancellations came around in December, Medaka Box’s first volume already sold more than enough to warrant keeping it over the other series it sold better AND collectively ranked better than.(Akaboshi and Kagijin) Despite what whiners and haters may say to try and discredit the feats this series has pulled off, Nishio’s name has not had any part in it surviving long enough to get its first volume released. Especially when a great number of WSJ series do not even survive long enough to make it to that point. I’ve already outlined the circumstances for each victory that has taken place. Bottom line is, series that sell well will trump series that rank extremely poorly and don’t have sales to save them.(I’ve already covered why Ane-Doki doesn’t count) To Love Ru and Nurarihyon no Mago are recent examples of series that sold well and managed to outlast other series despite having crappy rankings at points of their run.
At the time of writing this, Volume 3 has gone on sale the first week of February and has increased the sales record yet again(96K in 2 weeks). This series is likely to continue selling well and further cementing why it deserves to live despite ranking poorly.